Free Trial

Anika Therapeutics (ANIK) SEC Filings & 10K Form

Anika Therapeutics logo
$17.25 +0.25 (+1.47%)
(As of 11/15/2024 ET)

Recent Anika Therapeutics SEC Filings

DateFilerForm TypeView
11/08/2024
1:17 PM
Anika Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
11/04/2024
3:41 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
6:20 AM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
6:16 AM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:06 PM
Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
4:21 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/11/2024
3:35 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:31 PM
Anika Therapeutics (Issuer)
Capper Joseph H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:32 PM
Anika Therapeutics (Issuer)
CONLEY SHERYL L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:32 PM
Anika Therapeutics (Issuer)
Fischetti Gary P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:33 PM
Anika Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:33 PM
Anika Therapeutics (Issuer)
Jellison William R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:34 PM
Anika Therapeutics (Issuer)
Larsen Glenn R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:34 PM
Anika Therapeutics (Issuer)
Richard Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:24 PM
Anika Therapeutics (Filer)
Form DEFA14A
06/05/2024
3:10 PM
Anika Therapeutics (Issuer)
Capper Joseph H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:10 PM
Anika Therapeutics (Issuer)
Griffin Stephen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:11 PM
Anika Therapeutics (Issuer)
Jellison William R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:31 PM
Anika Therapeutics (Subject)
Caligan Partners LP (Filed by)
Form SC 13D/A
05/28/2024
4:04 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
4:15 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
3:12 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
7:48 AM
Anika Therapeutics (Filer)
Form 10-K/A
04/05/2024
11:21 AM
Anika Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
03/19/2024
4:23 PM
Anika Therapeutics (Issuer)
Levitz Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
11:20 AM
Anika Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2024
3:10 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
7:01 PM
Anika Therapeutics (Issuer)
Levitz Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:02 PM
Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:03 PM
Anika Therapeutics (Issuer)
Colleran David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:04 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:30 PM
Anika Therapeutics (Subject)
Caligan Partners LP (Filed by)
Form SC 13D/A
02/26/2024
8:00 AM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
10:09 AM
Anika Therapeutics (Subject)
Trigran Investments, Inc. (Filed by)
Form SC 13G/A
01/24/2024
1:27 PM
Anika Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/22/2024
9:52 AM
Anika Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
8:29 AM
Anika Therapeutics (Filer)
Form S-8 POS
01/19/2024
3:52 PM
Anika Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/12/2024
3:35 PM
Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
Form 3/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ANIK) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners